While media coverage of Zika virus (“Zika”) has died down in recent months, the public health crisis is ongoing. In August 2016, we explored the background and history of Zika. Since that time, Zika has continued to spread and there...

VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (“VBI”) is scheduled to present at the Keystone Symposia on Translational Vaccinology for Global Health on Thursday, October 27, 2016 at 7:00 PM BST (2:00 PM ET). The event is being held at...

1In 1947, Zika was first isolated in a rhesus monkey in the Zika forest of Uganda.2In 2007, the first large Zika outbreak in humans occurred in the Pacific Island of Yap, in the Federated States of Micronesia.3In October 2013, another...

VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (“VBI”) today announced that it has applied its clinical-stage eVLP Platform to the development of a novel vaccine candidate to prevent Zika virus (“Zika”) infection. “The alarming rise of Zika, and the sharp...

About VBI Vaccines

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. Learn More >>